Works matching IS 11738804 AND DT 2022 AND VI 36 AND IP 3

Results: 10

HLX11, a Proposed Pertuzumab Biosimilar: Pharmacokinetics, Immunogenicity, and Safety Profiles Compared to Three Reference Biologic Products (US-, EU-, and CN-Approved Pertuzumab) Administered to Healthy Male Subjects.

Published in:

BioDrugs, 2022, v. 36, n. 3, p. 393, doi. 10.1007/s40259-022-00534-w

By:

Yang, Jingjing;
Lin, Lili;
Long, Qihe;
Zhang, Qian;
Sun, Guilan;
Zhou, Liang;
Wang, Qingyu;
Zhu, Jun;
Li, Fanfan;
Hu, Wei

Publication type:

Article

Regulatory Evaluation of Biosimilars: Refinement of Principles Based on the Scientific Evidence and Clinical Experience.

Published in:

BioDrugs, 2022, v. 36, n. 3, p. 359, doi. 10.1007/s40259-022-00533-x

By:

Kurki, Pekka;
Kang, Hye-Na;
Ekman, Niklas;
Knezevic, Ivana;
Weise, Martina;
Wolff-Holz, Elena

Publication type:

Article

Novel Migraine Therapies May Reduce Public and Personal Disadvantages for People with Migraine.

Published in:

BioDrugs, 2022, v. 36, n. 3, p. 337, doi. 10.1007/s40259-022-00532-y

By:

Ambat, Fidel Dominique Festin;
Bentivegna, Enrico;
Martelletti, Paolo

Publication type:

Article

Dengue Vaccines: An Update.

Published in:

BioDrugs, 2022, v. 36, n. 3, p. 325, doi. 10.1007/s40259-022-00531-z

By:

Torres-Flores, Jesús M.;
Reyes-Sandoval, Arturo;
Salazar, Ma Isabel

Publication type:

Article

Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale.

Published in:

BioDrugs, 2022, v. 36, n. 3, p. 341, doi. 10.1007/s40259-022-00530-0

By:

Cohen, Fred;
Yuan, Hsiangkuo;
Silberstein, Stephen D.

Publication type:

Article

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.

Published in:

BioDrugs, 2022, v. 36, n. 3, p. 231, doi. 10.1007/s40259-022-00529-7

By:

Strohl, William R.;
Ku, Zhiqiang;
An, Zhiqiang;
Carroll, Stephen F.;
Keyt, Bruce A.;
Strohl, Lila M.

Publication type:

Article

Embracing Change: An International Survey Study on the Beliefs and Attitudes of Pediatric Rheumatologists Towards Biosimilars.

Published in:

BioDrugs, 2022, v. 36, n. 3, p. 421, doi. 10.1007/s40259-022-00526-w

By:

Demirkan, Fatma Gül;
Sönmez, Hafize Emine;
Lamot, Lovro;
Akgün, Özlem;
Sözeri, Betül;
Ayaz, Nuray Aktay

Publication type:

Article

Neoadjuvant Immune Checkpoint Inhibitor Therapy in Melanoma: Efficacy, Safety and Timing.

Published in:

BioDrugs, 2022, v. 36, n. 3, p. 373, doi. 10.1007/s40259-022-00525-x

By:

van Akkooi, Alexander C. J.;
Zijlker, Lisanne P.;
Wouters, Michel W. J. M.

Publication type:

Article

Clinical Features and Drug Retention of TNF Inhibitors in Older Patients with Ankylosing Spondylitis: Results from the KOBIO Registry.

Published in:

BioDrugs, 2022, v. 36, n. 3, p. 411, doi. 10.1007/s40259-022-00524-y

By:

Kim, Ji-Won;
Lee, Eunyoung A.;
Kim, Hyoun-Ah;
Suh, Chang-Hee;
Jung, Ju-Yang

Publication type:

Article

Comparative Treatment Persistence with Bone-Targeting Agents Among Asian Patients with Bone Metastases from Solid Tumors: A Multinational Retrospective Cohort Study.

Published in:

BioDrugs, 2022, v. 36, n. 3, p. 381, doi. 10.1007/s40259-022-00528-8

By:

Shen, Chin-Yao;
Au, Philip Chun-Ming;
Baek, Yeon-Hee;
Cheung, Ching-Lung;
Chung, Wei-Pang;
Kim, Ju Hwan;
Kleinman, Nora J.;
Lam, Tai-Chung;
Liao, Tzu-Chi;
Lin, Tzu-Chieh;
Shin, Ju-Young;
Sing, Chor-Wing;
Wong, Ian Chi Kei;
Lai, Edward Chia-Cheng

Publication type:

Article